[Prolactin adenomas in women under 20 years of age: apropos of 11 cases]. 1988

O Cáceres Narizzano, and I Molocznik, and R Artese, and A Kulczycki, and L Boero, and E Caputi

UI MeSH Term Description Entries
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015175 Prolactinoma A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA. Adenoma, Prolactin-Secreting, Pituitary,PRL-Secreting Pituitary Adenoma,Pituitary Adenoma, Prolactin-Secreting,Lactotroph Adenoma,Macroprolactinoma,Microprolactinoma,Prolactin-Producing Pituitary Adenoma,Prolactin-Secreting Pituitary Adenoma,Prolactinoma, Familial,Adenoma, Lactotroph,Adenomas, Lactotroph,Lactotroph Adenomas,Macroprolactinomas,Microprolactinomas,PRL Secreting Pituitary Adenoma,PRL-Secreting Pituitary Adenomas,Pituitary Adenoma, PRL-Secreting,Pituitary Adenoma, Prolactin Secreting,Pituitary Adenoma, Prolactin-Producing,Pituitary Adenomas, PRL-Secreting,Pituitary Adenomas, Prolactin-Producing,Pituitary Adenomas, Prolactin-Secreting,Prolactin Producing Pituitary Adenoma,Prolactin Secreting Pituitary Adenoma,Prolactin-Producing Pituitary Adenomas,Prolactin-Secreting Pituitary Adenomas,Prolactinomas

Related Publications

O Cáceres Narizzano, and I Molocznik, and R Artese, and A Kulczycki, and L Boero, and E Caputi
January 1974, Revue d'oto-neuro-ophtalmologie,
O Cáceres Narizzano, and I Molocznik, and R Artese, and A Kulczycki, and L Boero, and E Caputi
January 1985, Annales de medecine interne,
O Cáceres Narizzano, and I Molocznik, and R Artese, and A Kulczycki, and L Boero, and E Caputi
January 1968, Bulletin de la Societe medicale d'Afrique noire de langue francaise,
O Cáceres Narizzano, and I Molocznik, and R Artese, and A Kulczycki, and L Boero, and E Caputi
October 1988, Ugeskrift for laeger,
O Cáceres Narizzano, and I Molocznik, and R Artese, and A Kulczycki, and L Boero, and E Caputi
January 1997, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
O Cáceres Narizzano, and I Molocznik, and R Artese, and A Kulczycki, and L Boero, and E Caputi
January 1980, Revista chilena de obstetricia y ginecologia,
O Cáceres Narizzano, and I Molocznik, and R Artese, and A Kulczycki, and L Boero, and E Caputi
January 1971, Bulletin de la Societe medicale d'Afrique noire de langue francaise,
O Cáceres Narizzano, and I Molocznik, and R Artese, and A Kulczycki, and L Boero, and E Caputi
January 1986, Journal of neuro-oncology,
O Cáceres Narizzano, and I Molocznik, and R Artese, and A Kulczycki, and L Boero, and E Caputi
November 1992, New York state journal of medicine,
O Cáceres Narizzano, and I Molocznik, and R Artese, and A Kulczycki, and L Boero, and E Caputi
February 2021, BMC pediatrics,
Copied contents to your clipboard!